NCT01449097

Brief Summary

The aim of this study is to investigate the efficacy of the Adductor-Canal-Blockade versus the femoral nerve block versus placebo on muscle strength in healthy volunteers. The investigators hypothesize that the Adductor-Canal-Blockade results in a lesser reduction of the quadriceps muscle strength compared to the femoral nerve block.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Oct 2011

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 7, 2011

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

December 22, 2011

Status Verified

December 1, 2011

Enrollment Period

1 month

First QC Date

October 6, 2011

Last Update Submit

December 21, 2011

Conditions

Keywords

Adductor-Canal-blockade,human volunteers,US-guided nerve blockfemoral nerve block

Outcome Measures

Primary Outcomes (1)

  • the difference in quadriceps muscle strength between the Adductor-Canal-Blockade and placebo

    0-6 hours

Secondary Outcomes (4)

  • The difference in quadriceps muscle strength between the Adductor-Canal-Blockade and the femoral nerve block

    0-6 hours

  • The difference in quadriceps muscle strength between the placebo and the femoral nerve block

    0-6 hours

  • The difference in adductor muscle strength between the groups

    0-6 hours

  • The difference in mobilization between the groups

    0-6 hours

Study Arms (3)

Adductor-Canal-Blockade

EXPERIMENTAL
Procedure: Adductor-Canal-Blockade

The femoral nerve block

ACTIVE COMPARATOR
Procedure: The femoral nerve block

Placebo

PLACEBO COMPARATOR
Procedure: Placebo

Interventions

US-guided Adductor-Canal-blockade with Ropivacaine

Adductor-Canal-Blockade

US-guided femoral nerve block with ropivacaine

The femoral nerve block
PlaceboPROCEDURE

US-guided Adductor-Canal-Blockade/femoral nerve block with saline

Placebo

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • written informed consent
  • ASA 1
  • BMI \> 18 og \< 25

You may not qualify if:

  • Can not cooperate to the exam
  • Do not speak or understand Danish
  • Drug allergy
  • Alcohol or drug abuse
  • Daily consumption of analgetics on prescription
  • Any drug intake within the last 48 hours
  • Neuromuscular defects in the femoral nere, the obturator nerve or the muscles of the thigh.
  • Previous surgery or trauma to the lower limb
  • Diabetes Mellitus
  • Intake of steroids, except steroids for inhalation
  • Physical exercise within the last 24 hours prior to Day 1 and 2 of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet

Copenhagen, 2100, Denmark

Location

Related Publications (1)

  • Jaeger P, Nielsen ZJ, Henningsen MH, Hilsted KL, Mathiesen O, Dahl JB. Adductor canal block versus femoral nerve block and quadriceps strength: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Anesthesiology. 2013 Feb;118(2):409-15. doi: 10.1097/ALN.0b013e318279fa0b.

Study Officials

  • Pia Jæger, MD

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 6, 2011

First Posted

October 7, 2011

Study Start

October 1, 2011

Primary Completion

November 1, 2011

Study Completion

November 1, 2011

Last Updated

December 22, 2011

Record last verified: 2011-12

Locations